Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2010.01222.x ◽

2010 ◽

Vol 12 (8) ◽

pp. 700-708 ◽

Author(s):

Y. Iwamoto ◽

A. Kashiwagi ◽

N. Yamada ◽

S. Terao ◽

N. Mimori ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Download Full-text

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Cardiovascular Diabetology ◽

10.1186/s12933-016-0407-4 ◽

2016 ◽

Vol 15 (1) ◽

Author(s):

Nobuya Inagaki ◽

Shin-ichi Harashima ◽

Nobuko Maruyama ◽

Yutaka Kawaguchi ◽

Maki Goda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Download Full-text

Efficacy and safety of ipragliflozin as an add-on to pioglitazone in Japanese patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study (the SPOTLIGHT study)

Diabetology International ◽

10.1007/s13340-014-0182-y ◽

2014 ◽

Vol 6 (2) ◽

pp. 104-116 ◽

Author(s):

Atsunori Kashiwagi ◽

Takanori Shiga ◽

Noriko Akiyama ◽

Kenichi Kazuta ◽

Atsushi Utsuno ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12235 ◽

2013 ◽

Vol 16 (5) ◽

pp. 418-425 ◽

Author(s):

T. Kadowaki ◽

K. Kondo

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

Diabetologia ◽

10.1007/s00125-021-05460-0 ◽

2021 ◽

Author(s):

Linong Ji ◽

Ying Du ◽

Min Xu ◽

Xiangjun Zhou ◽

Zhaohui Mo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Phase Ii ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Treatment Naïve

Download Full-text

A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control

Diabetes Obesity and Metabolism ◽

10.1111/dom.14331 ◽

2021 ◽

Author(s):

Takashi Kadowaki ◽

Yutaka Seino ◽

Kohei Kaku ◽

Taro Okamoto ◽

Miho Kameya ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Therapy ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety

Download Full-text

Decision letter for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Review for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v1/review2 ◽

2019 ◽

Author(s):

Bastiaan E de Galan

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12555 ◽

2015 ◽

Vol 17 (12) ◽

pp. 1198-1201 ◽

Author(s):

K. Kaku ◽

M. Katou ◽

M. Igeta ◽

T. Ohira ◽

H. Sano

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Comparative Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Download Full-text

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

Diabetes Care ◽

10.2337/dc12-0706 ◽

2012 ◽

Vol 36 (2) ◽

pp. 237-244 ◽

Author(s):

J. B. McGill ◽

L. Sloan ◽

J. Newman ◽

S. Patel ◽

C. Sauce ◽

...

Keyword(s):

Type 2 Diabetes ◽

Renal Impairment ◽

Severe Renal Impairment ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text